Search Results 11-20 of 17099 for nivolumab
A combined treatment with nivolumab and ipilimumab, chemotherapy, and radiation therapy might be more effective in patients with esophageal and gastroesophageal ...
The purpose of this study is to determine whether Nivolumab in combination ... Nivolumab by itself in treating unresectable Melanoma or Melanoma that has spread ...
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility. Participant eligibility ...
... nivolumab and cabozantinib work in treating taxane pretreated patients with soft tissue sarcoma. Nivolumab works through the body's immune system to help ...
In-home Versus In-Clinic Subcutaneous Nivolumab Administration Through Connected And Remote Cancer CARE Beyond Walls · Overview · Participation eligibility.
The purpose of the study is to compare the efficacy and safety of nivolumab administered alone versus bevacizumab in patients diagnosed with recurrent ...
Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells. Participation eligibility. Participant ...
Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...
The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!